Last €3.69 EUR
Change Today +0.016 / 0.44%
Volume 0.0
RYIN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 2:20 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric H. Bjerkholt

Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Development & Finance and Corporate Secretary, Sunesis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 3 different industries.

See Board Relationships
53$672,554
As of Fiscal Year 2012

Background*

Mr. Eric H. Bjerkholt has been the Chief Financial Officer of Sunesis Pharmaceuticals Inc. since January 2004 and as its Executive Vice President of Corporate Development & Finance since February 2, 2012. Mr. Bjerkholt also serves as Principal Accounting Officer and Secretary of Sunesis Pharmaceuticals Inc. and previously served as its Senior Vice President of Corporate Development and Finance since February 2007. Mr. Bjerkholt has several years of experience and expertise ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

2004-Present
Director, Chairman of Audit Committee, Member of Compensation & Stock Option Committee and Member of Strategic Transactions Committee

Education*

MBA
Harvard Business School
Bachelor's Degree
Oslo and Akershus University College of Applied Sciences

Other Affiliations*

Annual Compensation*

Salary$367,500
Total Annual Compensation$367,500

Stock Options*

All Other Compensation$3,466
Exercisable Options326,287
Unexercisable Options392,708
Total Number of Options718,995

Total Compensation*

Total Annual Cash Compensation$518,966
Total Short Term Compensation$367,500
Other Long Term Compensation$3,466
Total Calculated Compensation$672,554
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RYIN:GR €3.69 EUR +0.016

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John R. Plachetka Pharm D.Co-Founder, Chairman, Chief Executive Officer and President
POZEN Inc.
$574.5K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.